The potential protective benefits associated with GLP-1 RAs reported in our study were primarily observed in new-onset HF, AKI or ESKD, VHD, cor pulmonale, and potential cardiac arrhythmia. The gene discussed is GLP1R; the disease is chronic obstructive pulmonary disease.